DJS Antibodies Company
![](/storage/logos_100px/DJS Antibodies.png)
Oncology, targetting tumour microenvironment. Building a pipeline of unique assets enabled by a world-leading platform for antibody discovery.
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
2014
Employees Number:
1-10
Funding Status:
Seed
Estimated Revenue:
Less than $1M
Register and Claim Ownership